Enzymatic desymmetrization of prochiral molecules

Current Organic Synthesis

Volumn 9, Issue 6, 2012, Pages 791-805

  Palomo, Jose M ^a   Cabrera, Zaida ^b  

^a INSTITUTO DE CATÁLISIS Y PETROLEOQUÍMICA   (Spain)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

Author keywords

Asymmetric hydrolysis; Asymmetric synthesis; Biocatalysis; Chiral intermediates; Desymmetrization; Enantioselectivity; Enzymes; Lipase; Prochiral compounds

Indexed keywords

EID: 84876900790     PISSN: 15701794     EISSN: None     Source Type: Journal    
DOI: 10.2174/157017912803901628     Document Type: Review

References (107)

1. Blaschke, G.; Kraft, H.P.; Fickentscher, K.; Kohler F. Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers. Arzneim.-Forsch., 1979, 29, 1640-1642.
2. Adams, S.S.; Bresloff, P.; Mason, G.G. Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-) isomer. J. Pharm. Pharmacol., 1976, 28, 256-257.
3. Perrotton, T.; Trompier, D.; Chang, X.; Di Prieto, A. Baubichon-Cortay, H. (R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1. J. Biol. Chem., 2007, 282, 31542-31548.
4. Caldwell, J. Do single enantiomers have something special to offer? Hum. Psychopharmacol., 2001, 15, S67-S71.
5. Pellissier, H. Recent developments in dynamic kinetic resolution. Tetrahedron, 2011, 67, 3769-3802.
6. Turner, N. J. Enzyme catalysed deracemisation and dynamic kinetic resolution reactions. Curr. Opin. Chem. Biol., 2004, 8, 114-119.
7. Ghanem, A.; Aboul-Enein, H.Y. Lipase-mediated chiral resolution of racemates in organic solvents. Tetrahedron: Asymmetry, 2004, 15, 3331-3351.
8. Deasy, R.; Brossat, M.; Moody, T.; Maguire, A. Lipase catalysed kinetic resolutions of 3-aryl alkanoic acids. Tetrahedron: Asymmetry, 2011, 22, 47-61.
9. Kamal, A.; Azhar, M.A.; Krishnaji, T.; Malik, M.S.; Azeeza, S. Approaches based on enzyme mediated kinetic to dynamic kinetic resolutions: A versatile route for chiral intermediates. Coord. Chem. Rev., 2008, 252, 569-592.
10. Ghanem, A. Trends in lipase-catalyzed asymmetric access to enantiomerically pure/enriched compounds. Tetrahedron, 2007, 63, 1721-1754.
11. Garcia-Urdiales, E.; Alfonso, I.; Gotor, V. Update 1 of: Enantioselective enzymatic desymmetrizations in organic synthesis. Chem. Rev., 2011, 111, PR110-PR180.
12. Garcia-Urdiales, E.; Alfonso, I.; Gotor, V. Enantioselective enzymatic desymmetrizations in organic synthesis Chem. Rev., 2005, 105, 313-354.
13. Gotor, V.; Alfonso, I.; Garcia-Urdiales, E. Asymmetric Organic Synthesis with Enzymes, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2008.
14. Reetz, M.T. Laboratory evolution of stereoselective enzymes: A prolific source of catalysts for asymmetric reactions. Angew. Chem. Int. Ed. 2011, 50, 138-174.
15. Wohlgemuth, R. Asymmetric biocatalysis with microbial enzymes and cells. Curr. Opin. Microbiol., 2010, 13, 283-292
16. Marques-Lopez, E.; Herrera, R.P.; Christmann, M. Asymmetric organocatalysis in total synthesis - A trial by fire. Nat. Prod. Rep., 2010, 27, 1138-1167.
17. Sangeetha, R.; Arulpandi, I.; Geetha, A. Bacterial lipases as potential industrial biocatalysts: An overview. Res. J. Microbiol., 2011, 6, 1-24.
18. Rodrigues, R.C.; Fernandez-Lafuente, R. Lipase from Rhizomucor miehei as an industrial biocatalyst in chemical process. J. Mol. Cat. B: Enzym., 2010, 64, 1-22.
19. Wiktelius, D. Lipases - Enzymes for biocatalytic asymmetric synthesis. Synlett, 2005; 13, 2113-2114.
20. Patel, R.N. Microbial/enzymatic synthesis of chiral intermediates for pharmaceuticals. Enzyme Microb. Technol., 2002, 31, 804-826.
21. Reetz, M. Lipases as practical biocatalysts. Curr. Opin. Chem. Biol., 2002, 6, 145-150.
22. Akai, S.; Kita, Y. Recent progress on the lipase-catalyzed asymmetric synthesis. J. Synth. Org. Chem., 2007, 65, 772-782.
23. Dominguez de Maria, P.; Garcia-Burgos C.A.; Bargeman G.; Van Germert R. Pig liver esterase (PLE) as biocatalyst in organic synthesis: From nature to cloning and to practical applications. Synthesis, 2007, 10, 1439-1452.
24. Patel, N.R. Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances. Curr. Opin. Biotechnol., 2001, 12, 587-604.
25. Grogan, G. Biotransformations. Annu. Rep. Prog. Chem., Sect. B: Org. Chem., 2007, 103,223-249.
26. Federsel, H-J. Asymmetry on large scale: The roadmap to stereoselective processes. Nat. Rev. Drug Discov., 2005, 4, 685-697.
27. Schindler, J.; Egressy, M.; Bereczki, L.; Pokol, G.; Fogassy, E.; Marthi, K. Enhanced efficiency due to the use of achiral additives in the optical resolution of 1-phenylethylamine by its glutaric acid derivative. Chirality, 2007, 19, 239-244.
28. Volpato, G.; Rodrigues, R.C.; Fernandez-Lafuente, R. Use of Enzymes in the Production of Semi-Synthetic Penicillins and Cephalosporins: Drawbacks and Perspectives. Curr. Med. Chem., 2010, 17, 3855-3873.
29. Sundaresan, V.; Abrol, R. Biological Chiral Recognition: The Substrate's Perspective. Chirality, 2005, 17, S30-S39.
30. Palomo, J.M. Modulation of enzymes selectivity via immobilization. Curr. Org. Synth., 2009, 6, 1-14.
31. Mateo, C.; Palomo, J.M.; Fernandez-Lorente, G.; Guisan, J.M.; Fernandez- Lafuente R. Improvement of enzyme activity, stability and selectivity via immobilization techniques. Enzyme Microb. Technol., 2007, 40, 1451-1463.
32. Yu, M.S.; Lantos, I.; Peng, Z.Q.; Lu, J.; Cacchio T. Asymmetric synthesis of (-)-paroxetine using PLE hydrolysis. Tetrahedron Lett., 2000, 41, 5647-5651.
33. Kubota, H.; Kakefuda, A.; Okamoto, Y.; Fujii, M.; Yamamoto, O.; Yamagiwa, Y.; Orita, M.; Ikeda, K.; Takeuchi, M.; Shibanuma, T.; Isomura, Y. Spiro-substituted piperidines as neurokinin receptor antagonists. III. Synthesis of (±)-N-[2-(3,4-dichlorophenyl)-4-(spiro-substituted piperidin-1'- yl)butyl]-N-methylbenzamides and evaluation of NK1-NK2 dual antagonistic activities. Chem Pharm Bull., 1998, 46, 1538-1544.
34. Chen, Y.; Zaks, A.; Chackalamannil, S.; Dugar, S. Asymmetric synthesis of substituted 2-azaspiro [3.5]nonan-1-ones: An enantioselective synthesis of the cholesterol absorption inhibitor (+)-SCH 54016. J. Org. Chem., 1996, 61, 8341-8343.
35. Ferna-ndez-Lorente, G.; Cabrera, Z.; Godoy, C.; Ferna-ndez-Lafuente, R.; Palomo, J.M.; Guisa-n, J.M. Interfacially activated lipases against hydrophobic supports: Effect of the support nature on the biocatalytic properties. Process Biochem., 2008, 43, 1061-1067.
36. Cabrera, Z.; Fernandez-Lorente, G.; Fernandez-Lafuente, R.; Palomo, J.M.; Guisan, J.M. Novozym 435 displays very different selectivity compared to lipase from Candida antarctica B adsorbed on other hydrophobic supports. J. Mol. Cat. B: Enzym., 2009, 57, 171-176.
37. Cabrera, Z.; Palomo, J.M.; Fernandez-Lorente, G.; Fernandez-Lafuente, R.; Guisan, J.M. Partial and enantioselective hydrolysis of diethyl phenylmalonate by immobilized preparations of lipase from Thermomyces lanuginose. Enzyme Microb. Technol., 2007, 40, 1280-1285.
38. Fernandez-Lorente, G.; Palomo, J.M.; Cabrera, Z.; Guisan, J.M.; Fernandez- Lafuente, R. Specificity enhancement towards hydrophobic substrates by immobilization of lipases by interfacial activation on hydrophobic supports. Enzyme Microb. Technol., 2007, 41, 565-569.
39. Cabrera, Z.; Lopez-Gallego, F.; Fernandez-Lorente, G.; Palomo, J.M.; Montes, T.; Grazu, V.; Guisan, J.M.; Fernandez-Lafuente, R. Asymmetric hydrolysis of dimethyl phenylmalonate by immobilized penicillin G acylase from E. coli. Enzyme Microb. Technol., 2007, 40, 997-1000.
40. Goswami, A.; Kissick, T. Enzymatic Desymmetrization of Dimethyl Cylcohex- 4-ene-cis-1,2-dicarboxylate to (1S,2R)-2-(Methoxycarbonyl) cyclohex- 4-ene-1-carboxylic Acid. Org. Proc. Res. Dev., 2009, 13, 483-488.
41. Carter, P.H.; Cherney, R.J.; Batt, D.G.; Duncia, J.V.; Gardner, D.S.; Ko, S.; Srivastava, A.S.; Yang, M.G. PCT Int. Appl.WO/2005/021500 A1, 2005.
42. Lewis, C.; Gustafson, J.; Chiu, A.; Balsells, J.; Pollard, D.; Murry, J.; Reamer, R.; Hansen, K.; Miller, S. A case of remote asymmetric induction in the peptide-catalyzed desymmetrization of a bis(phenol). J. Am. Chem. Soc., 2008, 130, 16358-16365.
43. Linnane, P.; Magnus, N.; Magnus, P. Induction of molecular asymmetry by a remote chiral group. Nature, 1997, 385, 799-801.
44. Clayden, J.; Lund, A.; Vallverdu, L.; Helliwell, M. Ultra-remote stereocontrol by conformational communication of information along a carbon chain. Nature, 2004, 431, 966-971.
45. Hughes, D.L.; Bergan, J.J.; Amato, J.S.; Bhupathy, M.; Leazer, J.L.; McNamara, J.M.; Sidler, D.R.; Reider, P.J.; Grabowski, E.J.J. Lipase-catalyzed asymmetric hydrolysis of esters having remote chiral/prochiral centers. J. Org. Chem., 1990, 55, 6252-6259.
46. Masterson, D.; Roy, K.; Rosado, D.; Fouche, M. A divergent approach to the preparation of cysteine and serine analogs. J. Pept. Sci., 2008, 14, 1151-1162.
47. Steer, D.L.; Lew, R.A.; Perlmutter, P.; Smith, A.I.; Aguilar, M.-I. -Amino acids: Versatile peptidomimetics. Curr. Med. Chem., 2002, 9, 811-822.
48. Ghorai, M.K.; Das, K.; Kumar, A. A convenient synthetic route to enantiopure N-tosylazetidines from -amino acids. Tetrahedron Lett., 2007, 48, 2471-2475.
49. Hong, E.Y.; Cha, M.; Yun, H.; Kim, B-G. Asymmetric synthesis of l-tertleucine and l-3-hydroxyadamantylglycine using branched chain aminotransferase. J. Mol. Cat. B: Enzym., 2010, 66, 228-233.
50. Iosub, V.; Haberl, A.; Leung, J.; Tang, M.; Vembaiyan, K.; Parvez, M.; Back, T. Enantioselective synthesis of a-quaternary amino acid derivatives by sequential enzymatic desymmetrization and curtius rearrangement of α,α,- disubstituted malonate diesters. J. Org. Chem., 2010, 75, 1612-1619.
51. Cativiela, C.; Ordonez, M. Recent progress on the stereoselective synthesis of cyclic quaternary α -amino acids. Tetrahedron: Asymmetry, 2009, 20, 1-63.
52. Vogt, H.; Brase, S. Recent approaches towards the asymmetric synthesis of α, α - disubstituted α -amino acids. Org. Biomol.Chem., 2007, 5, 406-430.
53. Prantz, K.; Mulzer, J. Synthesis of (Z)-Trisubstituted olefins by decarboxylative Grob-Type fragmentations: Epothilone D, discodermolide, and peloruside A. Chem. Eur. J., 2010, 16, 485-506.
54. Mulzer, J.; Altmann, K.-H.; Hofle, G.; Muller, R.; Prantz, K. Epothilones - A fascinating family of microtubule stabilizing antitumor agents. Compt. Rend. Chim., 2008, 11, 1336-1368.
55. Belardi, J.K.; Micalizio, G.C. Conversion of allylic alcohols to stereodefined trisubstituted alkenes: A complementary process to the claisen rearrangement. J. Am. Chem. Soc., 2008, 130, 16870-16872.
56. Schmidt, J.P.; Beltran-Rodil, S.; Cox, R.; McAllister, G.; Reid, M.; Taylor, R. The first synthesis of the ABC-ring system of 'upenamide. Org. Lett., 2007, 9, 4041-4044.
57. Menard-Moyon, C.; Taylor, R.J.K. Stereoselective syntheses of the octahydropyrano[ 2,3-b]pyridine DE core of 'upenamide via a stannous chlorideinduced deacetalisation-cyclisation procedure. Eur. J. Org. Chem., 2007, 3698-3706.
58. Zutter, U.; Iding, H.; Spurr, P.; Wirz, B. New, efficient synthesis of oseltamivir phosphate (Tamiflu) via enzymatic desymmetrization of a meso-1,3- cyclohexanedicarboxylic acid diester. J. Org. Chem., 2008, 73, 4895-4902.
59. Kim, C.U.; Lew, W.; Williams, M.A.; Wu, H.; Zhang, L.; Chen, X.; Escarpe, P.A.; Mendel, D.B.; Laver, W.G.; Stevens, R.C. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. J. Med. Chem., 1998, 41, 2451-2460.
60. Daly, J.W.; Spande, T.F.; Garraffo, H.M. Alkaloids from amphibian skin: A tabulation of over eight-hundred compounds. J. Nat. Prod., 2005, 68, 1556-1575.
61. O'Hagan, D. Pyrrole, pyrrolidine, pyridine, piperidine and tropane alkaloids. Nat. Prod. Rep., 2000, 17, 435-446.
62. Curtis, K.L.; Fawcett, J.; Handa, S. The first asymmetric synthesis of (2S,3S,4R)-3-amino-2-hydroxymethyl-4- hydroxypyrrolidine. Tetrahedron Lett., 2005, 46, 5297-5300.
63. Sun, H.; Abboud, K.A.; Horenstein, N.A. A new route into hexahydrocyclopenta[ b]pyrrole-cis-3a,6-diols. Synthesis of constrained bicyclic analogues of pyrrolidine azasugars. Tetrahedron 2005, 61, 10462-10469.
64. Compain, P.; Martin, O.R. Iminosugars: From Synthesis to Therapeutic Applications Eds.; Wiley: Chichester, 2008.
65. Chenevert, R.; Jacques, F.; Giguere, P.; Dasser, M. Enzymatic desymmetrization of pyrrolidine and pyrroline derivatives. Tetrahedron: Asymmetry, 2008, 19, 1333-1338.
66. Patel, R.N.; Banerjee, A.; Pendri, Y.R.; Liang, J.; Chen, C.-P.; Mueller, R. Preparation of a chiral synthon for an HBV inhibitor: Enzymatic asymmetric hydrolysis of (1α,2β,3α)-2-(benzyloxymethyl)cyclopent-4-ene-1, 3-diol diacetate and enzymatic asymmetric acetylation of (1α,2β, 3α)-2- (benzyloxymethyl)cyclopent-4-ene-1,3-diol. Tetrahedron: Asymmetry, 2006, 17, 175-178.
67. Mendelsohn, R.B.; Taur, Y.; Ng, G.; Patel, D.; Kamboj, M.; Zelenetz, A.D.; Sepkowitz, K.; Ludwig, E. Entecavir is Effective in Preventing Hepatitis B Reactivation in Cancer Patients Receiving Chemotherapy. Gastroenterology, 2011, 140, S-930.
68. Zhao, Z.; Mariano, P. Application of the photocyclization reaction of 1,2- cyclopenta-fused pyridinium perchlorate to formal total syntheses of (-)- cephalotaxine. Tetrahedron, 2006, 62, 7266-7273.
69. Zhao, Z.; Duesler, E.; Wang, C.; Guo, H.; Mariano P. Photocyclization reactions of cyclohexa- and cyclopenta-fused pyridinium salts. Factors governing regioselectivity. J. Org. Chem., 2005, 70, 8508-8512.
70. Isono, N.; Mori, M. Total synthesis of (-)-cephalotaxine. J. Org. Chem., 1995, 60, 115-119.
71. Joung, Y.C.; Borch R.F. Highly efficient synthesis of enantiomerically enriched 2-hydroxymethylaziridines by enzymatic desymmetrization. Org. Lett., 2007, 9, 215-218.
72. Sweeney, J.B. Aziridines: Epoxides' ugly cousins? Chem. Soc. Rev., 2002, 31, 247-258.
73. McCoull, W.; Davis, F.A. Recent synthetic applications of chiral aziridines. Synthesis, 2000, 1347-1365.
74. Hinterding, K.; Albert, R.; Cottens, S. First asymmetric synthesis of chiral analogues of the novel immunosuppressant FTY720. Tetrahedron Lett., 2002, 43, 8095-8097.
75. Hinterding, K.; Cottens, S.; Albert, R.; Zecri, F.; Buehlmayer, P.; Spanka, C.; Brinkmann, V.; Nussbaumer, P.; Ettmayer, P.; Hoegenauer, K.; Gray, N; Pan, S. Synthesis of chiral analogues of FTY720 and its phosphate. Synthesis, 2003, 1667-1670.
76. Adachi, K.; Kohara, T.; Nakao, N.; Arita, M.; Chiba, K.; Mishina, T.; Sasaki, S.; Fujita, T. Design, synthesis, and structure-activity relationships of 2- substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720 Bioorg. Med. Chem. Lett., 1995, 5, 853-856.
77. Brinkmann, V.; Lynch, K.R. Transplantation. Curr.Opin. Immunol., 2002, 14, 559-561.
78. Nakamura, T.; Tsuji, T.; Iio, Y.; Miyazaki, S.; Takemoto, T.; Nishi, T. Asymmetric synthesis of α,α-disubstituted _-amino alcohol derivatives. Tetrahedron: Asymmetry, 2006, 17, 2781-2792.
79. Rios-Lombardia, N.; Gotor-Fernandez, V.; Gotor, V. Complementary lipasemediated desymmetrization processes of 3-Aryl-1,5-disubstituted fragments. enantiopure synthetic valuable carboxylic acid derivatives. J. Org. Chem., 2011, 76, 811-819.
80. Kawasaki, M.; Toyooka, N.; Saka, T.; Goto, M.; Matsuya, Y.; Kometani T. Lipase-mediated preparation of optically active isomers of Rosaphen®. J. Mol. Cat. B: Enzym., 2010, 67, 135-142.
81. Chenevert, R.; Courchesne, G.; Pelchat, N. Chemoenzymatic synthesis of both enantiomers of α-tocotrienol. Bioorg. Med. Chem., 2006, 14, 5389-5396.
82. Miyazawa, T.; Shibata, A.; Sookwong, P.; Kawakami, Y.; Eitsuka, T.; Asai, A.; Oikawa, S.; Nakagawa, K. Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol). J. Nutr. Biochem., 2009, 20, 79-86.
83. Serbinova, E.; Kagan, V.; Han, D.; Packer, L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic. Biol.Med., 1991, 10, 263-275.
84. Kohler, J.; Wunsch, B. Lipase catalyzed enantioselective desymmetrization of a prochiral pentane-1,3,5-triol derivative. Tetrahedron: Asymmetry, 2006, 17, 3091-3099.
85. Pitt, S.W.; Zhang, Q.; Patel, D.J.; Al-Hashimi, H.M. Evidence that electrostatic interactions dictate the ligand-induced arrest of RNA global flexibility. Angew. Chem., Int. Ed., 2005, 44, 3412-3415.
86. Blount, K.F.; Zhao, F.; Hermann, T.; Tor, Y. Conformational constraint as a means for understanding RNA-aminoglycoside specificity. J. Am. Chem. Soc., 2005, 127, 9818-9829.
87. Liang, F.S.; Wang, S.K.; Nakatani, T.; Wong, C.H. Targeting RNAs with tobramycin analogues. Angew. Chem. Int. Ed., 2004, 43, 6496-6500.
88. Chenevert, R.; Jacques, F. Enzymatic desymmetrization of 2,5- dideoxystreptamine precursors. Tetrahedron: Asymmetry, 2006, 17, 1017-1021.
89. Chenevert, R.; Morin, P. Synthesis of (-)-lobeline via enzymatic desymmetrization of lobelanidine. Bioorg. Med. Chem., 2009, 17, 1837-1839.
90. Felpin, F.X.; Lebreton, J. History, chemistry and biology of alkaloids from Lobelia inflate. Tetrahedron, 2004, 60, 10127-10153.
91. Wilhelm, C.J.; Johnson, R.A.; Eshleman, A.J.; Janowsky, A. Lobeline effects on tonic and methamphetamine-induced dopamine release. Biochem. Pharmacol., 2008, 75, 1411-1415.
92. Zheng, G.; Dwoskin, L.P.; Deaciuc, A.G.; Crooks, P.A. Synthesis and evaluation of a series of homologues of lobelane at the vesicular monoamine transporter-2. Bioorg. Med. Chem. Lett., 2008, 18, 6509-6512.
93. Zheng, G.; Dwoskin, L.P.; Crooks, P. Vesicular monoamine transporter 2: Role as a novel target for drug development. A. AAPS J., 2006, 8, E682.
94. Magauer, T.; Martin, H.J.; Mulzer, J. Total synthesis of the antibiotic kendomycin by maerocyclization using photo-fries rearrangement and ringclosing metathesis. Angew. Chem., Int. Ed., 2009, 48, 6032-6036.
95. Lucas, B.S.; Gopalsamuthiram, V.; Burke, S.D. Total synthesis of phorboxazole B. Angew. Chem., Int. Ed., 2007, 46, 769-772.
96. Williams, D.R.; Ihle, D.C.; Plummer, S. V. Total synthesis of (-)-ratjadone. Org. Lett., 2001, 3, 1383-1386.
97. Candy, M.; Audran, G.; Bienayme, H.; Bressy, C.; Pons, J.M. Enantioselective enzymatic desymmetrization of highly functionalized meso tetrahydropyranyl diols. Org. Lett., 2009, 11, 4950-4953.
98. Yadav, J.S.; Reddy, P.V.; Chandraiah, L. A formal total synthesis of crocacin C. Tetrahedron Lett., 2007, 48, 145-148.
99. Candy, M.; Audran, G.; Bienayme, H.; Bressy, C.; Pons, J.M. Total synthesis of (+)-crocacin C using hidden symmetry. J. Org. Chem., 2010, 75, 1354-1359.
100. Rios-Lombardia, N.; Busto, E.; Gotor-Fernandez, V.; Gotor, V. Synthesis of optically active heterocyclic compounds by preparation of 1,3-dinitro derivatives and enzymatic enantioselective desymmetrization of prochiral diamines. Eur. J. Org. Chem., 2010, 484-493.
101. Rios-Lombardia, N.; Busto, E.; Garcia-Urdiales, E.; Gotor-Fernandez, V.; Gotor, V. Enzymatic desymmetrization of prochiral 2-substituted-1,3- diamines: Preparation of valuable nitrogenated compounds. J. Org. Chem., 2009, 74, 2571-2574.
102. Busto, E.; Gotor-Fernandez, V.; Montejo-Bernardo, J.; Garcia-Granda, S.; Gotor, V. Development of a chemoenzymatic strategy for the synthesis of optically active and orthogonally protected polyamines. Tetrahedron, 2009, 65, 8393-8401.
103. Breuer, M.; Ditrich, K.; Habicher, T.; Hauer, B.; Kesseler, M.; Stuermer, R.; Zelinski, T. Industrial methods for the production of optically active intermediates. Angew. Chem., Int. Ed., 2004, 43, 788-824
104. Turner, N.J.; Carr, R. In Biocatalysis in the Pharmaceutical and Biotechnology Industries; Patel, R. N., Ed.; CRC: Boca Raton, FL, 2007, 743-755.
105. Fryszkowska, A.; Komar, M.; Koszelewski, D.; Ostaszewski, R. Studies on enzymatic synthesis of chiral non-racemic 3-arylglutaric acid monoesters. Tetrahedron: Asymmetry, 2006, 17, 961-966.
106. Chenevert R.; Desjardins M. Chemoenzymatic enantioselective synthesis of baclofen. Can. J. Chem., 1994, 72, 2312-2317.
107. Fryszkowska, A.; Komar, M.; Koszelewskia, D.; Ostaszewski, R. Enzymatic desymmetrization of 3-arylglutaric acid anhydrides. Tetrahedron: Asymmetry, 2005, 16, 2475-2485.